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Recessive mutations in the amyotrophic lateral sclerosis 2 (ALS2) gene have 
been linked to juvenile-onset ALS2. Although one of the molecular functions of 
the ALS2 protein is clearly the activation of Rab5, the mechanisms underlying 
the selective dysfunction and degeneration of motor neurons in vivo remain 
to be fully understood. Here we focused on the ALS2 homolog of Drosophila 
melanogaster, isolated two independent deletions, and systematically 
compared phenotypes of the mutants with those of animals in which Rab5 
function in identified neurons was abrogated. In the dALS2 mutant flies, we 
found that the stereotypic axonal and dendritic morphologies of neurons shared 
some features with those in Rab5-deficient flies, but the dALS2 mutant 
phenotypes were much milder. We also found that the abrogation of Rab5 
function in motor neurons strongly depressed the locomotion activity of adults, 
resembling the behavior of aged dALS2 mutants. Importantly, this age-
dependent locomotion deficit of dALS2 mutants was restored to normal by 
expressing the dALS2 transgene in a wide range of tissues. This finding 
provided a platform where we could potentially identify particular cell types 
responsible for the phenotype by tissue-specific rescue experiments. We 






Motor neuron diseases (MNDs) are a group of progressive neurological 
disorders. They are caused by degeneration of upper motor neurons (UMNs) 
of the motor cortex in brain and lower motor neurons (LMNs) in brainstem 
and spinal cord. One of the best-characterized forms of MND is amyotrophic 
lateral sclerosis (ALS), in which loss of UMNs with or without LMN 
involvement leads to muscle atrophy, fasciculations, and spasticity 
(Robberecht & Philips. 2013; Boillee et al. 2006; Pasinelli & Brown 2006). To 
elucidate the molecular pathogenesis for these diseases, the functions of the 
causative genes have been investigated. One of these is ALS2, which was 
originally discovered through genetic mapping and the identification of 
recessive mutations in juvenile-onset ALS families, and its clinical features 
include spasticity of limb and facial muscles accompanying distal amyotrophy 
of hands and feet (Ben Hamida et al. 1990; Hadano et al. 2007; Cai et al. 
2008; Kato 2008).  
       Human ALS2 protein (often designated as Alsin) comprises several 
domains that are characteristic of guanine nucleotide exchange factors 
(GEFs): an RCC1-like domain (RLD), the Dbl homology and pleckstrin 
homology (DH/PH), and the vacuolar protein sorting 9 (VPS9) domain. The 
VPS9 domain of ALS2 specifically binds to Rab5 and functions as its GEF 
(Otomo et al. 2003; Kunita et al. 2004). The majority of ALS2 mutations 
generate premature termination codons, resulting in protein instability and 
loss of function of ALS2 (Yamanaka et al. 2003). Cell biological assays 
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suggest that ALS2 dysfunction affects multiple contexts of endosomal 
trafficking through a Rab5-mediated mechanism (Devon et al. 2006; Hadano 
et al. 2006; Otomo et al. 2008; Lai et al. 2009), including formation of 
amphisomes, the hybrid-organelle formed upon fusion between 
autophagosomes and endosomes (Otomo et al. 2011). Although it has been 
hypothesized that this loss of GEF function could result in neuronal 
dysfunction and degeneration, mechanisms that lead to a selective 
dysfunction and degeneration of motor neurons in vivo remain to be fully 
understood. 
To study the underlying pathologic mechanisms of ALS2 deficiency 
in vivo, ALS2 knockout mice have been generated and characterized (Cai et 
al. 2005; Devon et al. 2006; Hadano et al. 2006; Yamanaka et al. 2006). 
Unexpectedly, the KO mice do not necessarily recapitulate clinical or 
neuropathological phenotypes consistent with the motor neuron disease. The 
KO mice do not show apparent overall locomotion deficits in their lifetime, 
except for a mild motor deficit in the Rotarod test (Deng et al. 2007) and 
slowed movement (Yamanaka et al. 2006); and no significant difference has 
been observed in the numbers of cortical or spinal motor neurons when 
compared to wild-type control mice (Cai et al. 2008). On the other hand, the 
KO mice are more vulnerable to oxidative stress than the wild-type controls 
(Cai et al. 2005), and expression of a pathogenic form of SOD1 (superoxide 
dismutase 1) in the ALS2 KO background aggravates the SOD1-associated 
disease symptoms such as body weight loss, motor dysfunction, and the 
accumulation of insoluble ubiquitinated proteins in the nervous system, 
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leading to earlier death (Hadano et al. 2010).  
Here we attempted to dissect the in vivo roles of ALS2 in the disease 
by taking advantage of another model organism, Drosophila melanogaster, 
for two main reasons. First, many of the human genes responsible for 
neurodegenerative diseases are conserved in the Drosophila genome, 
including ALS2 (see below). Second, a number of versatile Drosophila 
genetic tools and knowledge of well-characterized stereotypic morphologies 
of neuronal subtypes can be leveraged to provide mechanistic insights on 
MND (Lessing & Bonini 2009; Jaiswal et al. 2012). For example, the 
Drosophila TBPH encodes a human homolog of TDP-43 that is found in 
cytoplasmic inclusions in ALS (Feiguin et al. 2009), and studies of its tissue-
specific knockdown suggest that that impaired pre-synaptic transmission is 
one of the earliest events in TDP-43-related pathogenesis (Diaper et al. 
2013). We focused on the Drosophila homolog of ALS2, isolated its mutants, 
characterized both anatomical and behavioral phenotypes, and compared 
these to what has been shown in human patients and KO mice.  
 6 
Results & Discussion  
 
CG7158 encodes a homolog of ALS2  
Annotated genes in the genome of Drosophila melanogaster include 
homologs of four human GEFs and two GTPase activating proteins (GAPs) 
(Figure 1A and S1). Among them, the predicted protein product of a single 
gene CG7158 shows similarities to ALS2/Alsin. Hereafter, CG7158 and its 
protein product are designated as dALS2 and dALS2 for simplicity, 
respectively. Both ALS2/Alsin and dALS2 contain four domains in the same 
order from their amino-terminals (Figure 1A), among which the “membrane 
occupation and recognition nexus (MORN)” motifs and the carboxyl-terminal 
“vacuolar protein sorting 9 (VPS9)” domain in human ALS2 are necessary for 
its selective GEF activity for Rab5 in vitro (Otomo et al. 2003). One distinctive 
difference between dALS2 and ALS2/Alsin is that dALS2 lacks a DH domain, 
which is adjacent to the PH domain in human ALS2 and provides a basis of 
its GEF activity for Rac1 (Kunita et al. 2007). Thus dALS2 could be a more 
Rab5-specific GEF compared to ALS2. 
 
CG7158/dALS2 has a GEF activity for Rab5 
To examine whether dALS2 does possess GEF activity or not, we co-
expressed dALS2 and a fluorescence resonance energy transfer (FRET) 
probe, Raichu-Rab5 in Drosophila S2 cells (Kitano et al. 2008). The probe 
comprised Venus (a modified YFP), the amino-terminal Rab5-binding domain of 
EEA1, SECFP (a modified CFP), and Rab5. In this probe design, the increase 
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in the emission ratio reflects an increase in the active GTP-bound form of Rab5 
relative to the inactive GDP-bound form in living cells (Kitano et al. 2008). The 
emission ratio was increased significantly when dALS2 was co-expressed 
(the blue bar of “dALS2[WT]” in Figure 1B) compared to the transfection of 
the vector (the blue bar labeled “Control” in Figure 1B). This increase in the 
ratio was indeed dependent on the conversion from the GDP-bound form to the 
GTP-bound one, as shown by the fact that the emission ratio of Raichu-
Rab5[S34N], a constitutive GDP-bound form (Entchev et al. 2000), was 
unchanged even in the presence of dALS2 (the red bar labeled “dALS2[WT]” 
in Figure 1B). We also studied the effects of substitutions of two conserved 
amino acid residues in the VPS9 domain (Figure 1A and S2), which are 
necessary for full GEF activity of ALS2 in vitro (Otomo et al. 2003). The two 
mutant forms of dALS2 (dALS2[P1425A] and dALS2[L1439A]) increased the 
FRET efficiency of Raichu-Rab5, but not to the same extent as the wild-type 
form (Figure 1B). Collectively, these results showed that the wild-type form of 
dALS2 has GEF activity for Rab5.  
 
dALS2 mutants are viable and fertile 
To study the in vivo consequences of dALS2 dysfunction, we mobilized an 
existing transposable element that was inserted 120 bp upstream of the 1st 
ATG of the dALS2 coding sequence and isolated two independent alleles 
(Ex44 and Ex54) that delete about 30% of the coding sequence, including the 
start codon and the entire RLD domain (Figure 2A). We also obtained precise 
jumpers, where the transposon excision restored the exact contiguous WT 
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sequence, and used homozygotes of two of these (Ex101/Ex101 and 
Ex95/Ex95) for subsequent analysis as controls or the wild-type animals. 
Homozygotes of either Ex44 or Ex54 were viable and fertile; and the adults 
looked morphologically normal. Thus dALS2 may be dispensable for viability 
in flies, as is the case in mice (Cai et al. 2005; Devon et al. 2006; Hadano et 
al. 2006; Yamanaka et al. 2006). For further phenotypic analysis, we mostly 
employed Ex44 with a larger deletion than Ex54, unless described otherwise, 
and designated Ex44 homozygotes as dALS2-/-. 
      RT-PCR analysis confirmed the deletion of the amino-terminal coding 
sequence of dALS2 in adult dALS2-/- flies (Figure 2B). To address whether 
truncated polypeptides might be made by translation initiation from internal 
ATG codons downstream of the deletion in dALS2-/-, we generated antibodies 
to the carboxyl-terminal VPS9 domain. Unfortunately however, our antibodies 
failed to detect endogenous dALS2 with high sensitivity (data not shown), 
thus we could not exclude the possibility of the generation of the truncated 
polypeptides. Nonetheless, it is known that ALS2 without the RLD domain no 
longer associates with endosomes (Yamanaka et al. 2003), so the truncated 
dALS2 polypeptides, if synthesized from Ex44 and Ex54 alleles, would most 
likely not be functional. 
 It is shown that Rab5 is widely expressed, albeit with different 
expression levels in different tissues including larval and adult nervous 
systems and imaginal discs (Chan et al. 2011). dALS2 is also expressed in a 
broad range of tissues including the nervous system and the epidermis in the 
embryo (Figure 2C), larval central nervous system, adult brains, and larval 
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and adult guts (St Pierre et al.). 
 
Morphological analysis of axon terminals and dendritic arborization of 
identified neurons in the dALS2 mutant and in wild-type flies expressing 
a dominant-negative form of Rab5 
We searched for neurological disorders in the dALS2-/- mutant. In parallel, we 
addressed how far we could explain the detected phenotypes of the 
mutants as the disregulation of Rab5 activity. To establish a basis for 
comparison, we expressed a dominant negative form of Rab5[S34N] 
(Entchev et al. 2000) in wild-type neurons and addressed whether this 
caused effects reminiscent of the mutant phenotypes (Figure 3).  
We initially focused on presynaptic terminals of motor axons that 
innervate abdominal body wall muscles and form neuromuscular junctions 
(NMJs) with stereotyped connectivity (Kohsaka et al. 2012; Menon et al. 2013). 
To visualize presynaptic terminals in larvae, we double-labeled presynaptic 
membranes and active zones (anti-HRP and anti- Bruchpilot (Brp), respectively; 
Coyle et al. 2004) and quantified the number of Brp-positive boutons (Figure 
3A). The number of the boutons that was normalized by the area of the 
innervated muscle was not significantly different between the wild type and the 
mutant (Figure 3B). We did not find a noticeable difference in the number of 
postsynaptic marker (Mhc-CD8:YFP:Sh; Zito et al. 1999) -positive boutons; 
neither did we find a significant difference in the size of the muscles imaged in 
Figure 3A and 3C (data not shown).  
We also imaged motor axons in whole-mount adults using a transgenic 
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marker (Figure 3E; Hebbar et al. 2006) and found that there was no noticeable 
defect in axonal growth in mutants at the ages of 3-4 days and 3 weeks. We 
further measured the area of each presynaptic arbor and counted the number of 
boutons at the ventral NMJ in 2 week-old adults (the magenta-line polygons of 
Figure 3F, and Figure 3G-3I). Although the normalized bouton number was not 
significantly different between the two genotypes (Figure 3I), the absolute value 
of the bouton number per terminal was increased in the mutant (Figure 3H).  
To express Rab5[S34N] in the motor neuron, we used OK371-
Gal4, an enhancer trap line where the Gal4 gene is inserted in the gene 
encoding a vesicular glutamate transporter promoter (Mahr & Aberle 2006). 
Rab5[S34N] expression resulted in an increase in the bouton number of 
presynaptic terminals of motor axons in larvae and adults (Figure 3C, 3D, 
3J, and 3K), and the Rab5[S34N] effect was more dramatic than the 
phenotype in the dALS2 mutant. In addition to the increase in the number of 
boutons, each bouton became smaller than that of the control axon 
terminals at larval NMJs (Figure 3C). From earlier experiments with 
Rab5[S34N], it is known that Rab5 controls synaptic transmission at larval 
NMJs (Wucherpfennig et al. 2003). In that study, Rab5[S34N] expression 
was kept low during embryonic and early larval stages so that it did not 
affect morphological development of NMJs.  
We employed dendritic arborization (da) neurons as another assay 
system (Figure S3A; Jan & Jan 2010; Shimono et al. 2009). Previously, we 
showed that Rab5[S34N] expression or a rab5 null mutation strongly downsizes 
and simplifies dendritic arbors of class IV da neurons (Satoh et al. 2008). Our 
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quantifications of the da neurons in the dALS2 mutant showed mild defects in 
dendrite morphogenesis (Figure S3B and S3C): the total dendritic length and the 
number of branch endings per cell decreased by 11 % and 19%, respectively, 
relative to wild type, while the coverage index was not altered (Figure S3C). The 
overexpression of dALS2[WT] did not cause an significant effect on 
morphological development of the NMJs or the dendritic arbors (Figure 3D and 
data not shown).  
Collectively, the dALS2 mutant exhibited much milder phenotypes 
compared to the severe effects of the abrogation of Rab5 function. This might be 
explained by a contribution of at least one of the other Rab5 GEFs, Rabex5, 
(Figure S1) to regulation of synaptic vesicles and dendrite morphogenesis (Mori 
et al. 2013; Sann et al. 2012).  
 
Mutant adults showed a lowered locomotion activity 
In addition to the cell morphological phenotypes, we found that Rab5[S34N] 
expression in the motor neurons strongly depressed the climbing ability of 
adults (Figure S4A and supplemental movies 1 and 2). This prompted us to 
perform the climbing assay with the dALS2-/- mutant adults, which revealed 
the most prominent phenotype, and it was an age-dependent locomotion 
deficit that was causally related to loss of dALS2 function (Figure 4 and 5).  
The locomotion assay employed was the negative geotaxis assay, 
which is an established method to test the climbing ability of Drosophila 
(Figure S4B-S4D; Ali et al. 2011; see details in Experimental procedures). 
We reared the dALS2-/- mutants with either of the controls (Ex101/Ex101 or 
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Ex95/Ex95) at the same time, and examined the climbing ability of the mutant 
flies (Figure 4). We found that the adult mutants showed a locomotion defect 
at 2 weeks after eclosion, but not at 1 week or younger ages. At 4 weeks 
after eclosion, most of the mutant females failed to reach a fixed height within 
the allowed time (Figure S4C and S4D). 
 
The locomotion deficit of the mutant was rescued by dALS2 transgene 
expression  
We addressed whether or not this adult-onset climbing disability could be 
restored by tissue-specific expression of the wild-type dALS2 cDNA. We 
started with broad expression, because dALS2 is also expressed outside the 
nervous system (St Pierre et al.), and because it has been suggested, but 
not rigorously demonstrated, that the motor neuron is the primary locus of 
ALS2 action in mice.  
To realize broad expression, we used Ubiquitin (Ubi)-Gal4 to drive 
expression of the wild-type dALS2 transgene in a wide range of tissues 
(Figure 5). As a negative control for the transgene expression, we tested the 
effect of mmRFP expression on the climbing ability. 2 week-old dALS2-/- 
adults showed lowered climbing ability, compared to wild-type, and this 
phenotype was restored to normal by dALS2 transgene expression in both 
females and males (compare blue and green data points in Figure 5B). These 
results showed that the age-dependent locomotion deficit is indeed a loss-
of-function phenotype of dALS2. This phenotype is reminiscent of the 
moderate, age-dependent deficit in motor coordination in ALS2-null mice 
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(Cai et al. 2005). 
We next attempted to address whether the cell-type-specific dALS2 
transgene expression in motor neurons could rescue the mutant phenotype 
(Figure 6). In this experiment, we employed OK371-Gal4. This rescue 
strategy, however, made the assessment of the recovery difficult. This is 
primarily because the dALS2 expression in the wild-type motor neurons 
caused a deleterious effect on the climbing activity (compare red data points 
with orange ones in Figure 6). The dALS2–expressing aged mutants of both 
females and males tended to improve the climbing ability when compared to 
mRFP-expressing aged-matched adults (compare blue points with green 
ones in Figure 6B), although our results did not reach statistical significance.  
The above results can be interpreted in several ways. First, dALS2 
is indeed required in the motor neuron; however, the motor neuron GAL4 
driver (OK371-Gal4) failed to correct the phenotype significantly because this 
Gal4-driven expression of dALS2 far exceeds the physiological range and 
disturbs precise spatial-temporal regulation of Rab5 activity. Second, dALS2 
is supplied in the motor neuron at larval stages by Ubi-GAL4 and a portion 
of the proteins persist and function at the adult stage (we found that Ubi-
GAL4 is expressed in the motor neuron in larvae, but not in adults). Third, 
dALS2 is critically required in cell types other than the motor neuron to 
prevent the deterioration of locomotion during aging (e.g., the presumptive 
“upper” motor neuron in flies); and Ubi-GAL4, not OK371-Gal4, is expressed 
in that cell type. Use of the rich resource of GAL4 stocks (Jenett et al. 2012) 
and searches for the stocks that realize appropriate expression levels of 
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dALS2 would allow us to distinguish these possibilities. 
 
Aging, longevity, and sensitivity to oxidative stress of the dALS2 mutant  
It is known that even wild-type flies decline in climbing performance over time 
(Ganetzky & Flanagan 1978; Le Bourg & Lints 1992). Therefore, we 
suspected that aging might be accelerated in the dALS2 mutant and/or that 
the mutant might be short-lived. As a part of normal aging, the expression of 
several essential autophagy genes decline in fly neural tissues, which is 
causative of accumulations of ubiquitinated proteins and p62/Ref(2)P (Bartlett 
et al. 2011; Simonsen et al. 2008; Tonoki et al. 2009). This has been shown by 
the facts that ubiquitin-positive puncta precociously appear in atg8 mutants, 
which are defective in autophagy, and that enhanced neuronal Atg8a expression 
suppresses the accumulation of insoluble ubiquitinated proteins (Simonsen et al. 
2008). Therefore we examined levels of ubiquitinated proteins and p62 in the 
wild-type and the dALS2 mutant adults at distinct ages (Figure S5).  
At the age of 3-4 days after eclosion, ubiquitin-positive puncta were 
barely detected immunohistochemically in any regions of the brains of the wild 
type or the dALS2 mutant, whereas they were found in 2 week-old adults 
irrespective of the genotypes (Figure S5A). Via western blot analysis of whole 
lysates, we did not find overt differences in the levels of ubiquitinated proteins 
and p62, between the genotypes, at either of the two ages investigated (Figure 
S5B); and we did not find a noticeable difference in the amount of insoluble 
ubiquitinated proteins (IUP), either (data not shown). In contrast to the dALS2 
mutant, ubiquitin-positive puncta precociously appeared in atg8 mutants as 
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previously reported (data not shown). Thus we did not find evidence for 
accelerated aging in the dALS2 mutant and our results suggest that dALS2 
plays a relatively minor role in protein homeostasis, compared to the core 
machinery of autophagy. 
Unexpectedly, the mutant (Ex44/Ex44) exhibited a significantly longer 
life span than either of the two wild type stocks (Ex101/Ex101 or Ex95/Ex95) 
under our experimental protocol (Figure S6A-S6D). However, the Ubi-Gal4-
dependent dALS2 transgene expression failed to normalize the life span of 
Ex44/Ex44 (data not shown); and homozygous females of another deletion allele 
(Ex54/Ex54) did not exhibit a similarly significant longevity phenotype (Figure 
S6E-S6F). Thus we could not conclude that the longevity phenotype of 
Ex44/Ex44 was due to the loss of dALS2 function. Nonetheless, it is fairly 
safe to conclude that the loss of dALS2 function does not reduce the life span. 
 Intrigued by the fact that the ALS2 KO mice are more sensitive to 
oxidative stress than the wild-type controls (Cai et al. 2005), we recorded 
survival of the wild type and dALS2 mutant adult flies (Ex44/Ex44 or 
Ex54/Ex54) when they were exposed to hydrogen peroxide-containing food 
(Vrailas-Mortimer et al. 2011). Under this condition, Ex44/Ex44 females, but 
not Ex44/Ex44 males, were more sensitive to the stress than the wild-type 
females, whereas we did not obtain reproducible results when Ex54/Ex54 
adults were tested. Again, we were unable to restore the supersensitive 
phenotype of Ex44/Ex44 females by the Ubi-Gal4-dependent dALS2 rescue 
experiment (data not shown). 
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Future utility of the Drosophila ALS models 
In this study, we pursued the possibility that the Drosophila dALS2 mutant could 
become a new animal model for investigating mechanistic insights of the 
disease. Our discovery of the age-dependent locomotion deficit has provided a 
platform, where we could potentially specify the responsible cell types, verify the 
common belief that the primary focus of dALS2 action is the UMN, and screen 
genetic backgrounds or drugs that could alleviate or possibly prevent the onset 
of the symptoms.  
In addition to animal behaviors and neuronal cell morphologies, the 
absence of dALS2 function could impact synaptic transmission. Control of Rab5 
activity is required for normal development of NMJ as described above; in 
addition, Rab5 regulates the efficacy of the evoked neurotransmitter release once 
the NMJ is formed (Wucherpfennig et al. 2003). So NMJs in the dALS2 mutant 
could be a target of physiological and ultrastructural investigations. Other future 
targets are pre-motor interneurons that control the neurotransmitter release at 
NMJ and further upstream neural circuits, which are functional counterparts of 
UMNs in mammals. Identification of such neurons and technical accessibility to 
those would allow us to readdress whether the markers of neuronal aging and/or 
the Drosophila homolog of TDP-43 are accumulated in those particular neuronal 
classes, and this approach may validate Drosophila as a tractable model of not 
only ALS2 but also other genetic causes of ALS. 
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Experimental procedures  
 
Fly stocks 
We used the Gal4-UAS system (Brand & Perrimon 1993) to express transgenes 
and to visualize motor neurons and da neurons. Gal4 driver strains employed 
were Gr-Gal4 lines (Weiss et al. 2011), OK371-Gal4 (Mahr & Aberle 2006), and 
Ubi-Gal4 (the Bloomington Stock Center). UAS stocks and others were UAS-
mCD8:GFP and UAS-myr-mRFP (mmRFP; the Bloomington Stock Center), 
UAS-mCD8:3xEGFP (Kakihara et al. 2008), UAS-Rab5[S43N] (Entchev et al. 
2000), Mhc-CD8:YFP:Sh (Zito et al. 1999), and atg82 (the Bloomington Stock 
Center). The P element of CG7158G4607 (the Bloomington Stock Center) was 
mobilized, and a total of one hundred and fifty excision lines were established. 
Genomic deletions within the CG7158 locus were identified by genomic PCR 
using primers (sequences of the two primers in Figure 2A are 5’-
GCGTATGCAAACCAGCAGTA-3’ and 5’-CCCGAAATCTTTGAGCTGAG-3’) and 




The FRET probes, Raichu-Rab5[WT] and Raichu-Rab5[S34N], are described 
(Kitano et al. 2008) and the DNA fragment encoding Raichu-Rab5 was inserted 
into a pUAST-based vector. The full-length coding sequence (CDS) of 
dALS2/CG7158 was amplified using pOT2-LD33266 (Berkeley Drosophila 
Genome Project) as a template and inserted into pUAST-3xHA to generate 
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pUAST-3xHA:dALS2[WT]. CDSs of dALS2[P1425A] and dALS2[L1439A] were 
generated by site-directed mutagenesis using two single-primer reactions. The 
primers were 5’-GGTGAGCGCTATCATGTTGT-3’ and 5’-
ACAACATGATAGCGCTCACC-3’ for dALS2[P1425A], and 5’-
ACCAGCGTGGGGAACAGCA-3’ and 5’-TGCTGTTCCCCACGCTGGT-3’ for 
dALS2 [L1439A]. The CDSs of dALS2[P1425A] and dALS2[L1439A] were also 
inserted into pUAST-3xHA. 
 
Drosophila S2 cells and FRET imaging 
S2 cells were cultured at 25°C in Schneider’s Drosophila medium (Gibco) 
containing 10% fetal bovine serum (Gibco) and penicillin/streptomycin, and 
passaged every 3 to 4 days. S2 cells were cotransfected with pDA-Gal4 (actin-
promoter Gal4; a gift from Fumio Matsuzaki’s lab), pUAST-Raichu-Rab5, and 
either of pUAST-3xHA:dALS2[WT], pUAST-3xHA:dALS2[P1425A], or pUAST-
3xHA:dALS2[L1439A] by using HilyMax (Dojindo), and used for microscopic 
analysis 2 days after transfection. FRET imaging was performed as described 
(Tsuyama et al. 2013). 
 
RT-PCR and in situ hybridization 
We isolated total RNA from wild type and dALS2-/- adults with an RNeasy kit 
(QIAGEN). After cDNA was synthesized by using Ready-To-GO RT-PCR Beads 
(GE Healthcare UK), expression of dALS2 and Actin5c was detected by using 
the following primers: 5’-TCTGCAGCAGTCCAGCACATAC-3’ and 5’-
CATTTTGCCGAAACCTTCAATG-3’ for dALS2, and 5’-
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GTGCTGTGTGGATACTCC-3’ and 5’-TGTGGTGCCAGATCTTCTCC-3’ for 
Actin5c. RNA probes for in situ hybridization were made by using a cDNA clone 
LD33266 (Berkeley Drosophila Genome Project) as a template and hybridized 
with fixed embryos essentially as described (Matsubara et al. ; Yamamoto et al. 
2006; Hattori et al. 2007). 
 
Production of antibodies and western blotting 
Guinea pigs were immunized with a GST protein that had been fused to the N-
terminal 410 amino acids of dALS2 to generate anti-N1 antibody, and the C-
terminal 196 amino acids to generate anti-C1 antibody. We solubilized dALS2-
expressing S2 cells by sonication in the sample buffer for sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE). The antibodies recognized 
dALS2 that was endogenously expressed in S2 cells and the one overexpressed 
by Ubi-Gal4 in transgenic flies (data not shown). Adult heads were homogenized 
in the sample solution and lysates were boiled immediately. The lysates were 
separated on 8% polyacrylamide gels in WIDE RANGE Gel Preparation Buffer 
for SDS-PAGE (Nacalai) and transferred to PVDF membranes (Millipore). To 
detect ubiquitinated proteins and p62 proteins, lysates equivalent to 7.5 fly heads 
were run per lane (Figure S5B). The primary antibodies were used at the following 
concentrations: guinea pig anti-dALS2 (1:1000), rabbit anti-p62 (1:4000; Pircs et 
al. 2012), mouse anti-polyubiquitin FK2 (1:1000; COSMO BIO), and mouse anti-





Wandering third instar larvae were dissected in PBS, fixed in PBS containing 
3.7% formaldehyde for 10 min, incubated in primary antibodies overnight at 4°C, 
and in secondary antibodies for 1-2 days at 4°C. Adult brains were fixed in PBS 
containing 3.7% formaldehyde for 1h. The primary antibodies were used at the 
following concentrations: rabbit anti-HRP (1:300; Jackson ImmunoResearch), 
mouse NC82 (1: 100; Developmental Studies Hybridoma Bank [DSHB] at the 
University of Iowa), mouse anti-polyubiquitin FK2 (1:500; COSMO BIO), and 
rabbit polyclonal antibody against Drosophila p62 protein (1:2000; Pircs et al. 
2012).  
  
Imaging and quantification 
In fillet preparations of wandering 3rd instar larvae, we counted the numbers of 
boutons of motor nerve endings at muscles 6/7 in segment A2 as previously 
described (Colyle et al. 2004). To acquire images of adult abdominal NMJs, we 
mounted abdomens as described (Shimono et al. 2009) and imaged motor nerve 
endings in the ventral plate. We quantified the area size of the nerve endings and 
the total number of boutons in segments A4 and A5 as described by Hebbar et al 
(2006). Images of larval da neurons were acquired and quantitatively analyzed 
essentially as described (Matsubara et al. 2011; Hattori et al. 2007; Parrish et al. 
2009).  
 
Negative geotaxis assay, longevity, and sensitivity to oxidant exposure 
Flies of each genotype were collected 1 day after eclosion, and mated for 1 day. 
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After this mating, males and females were separated, and sorted into ten groups 
of ten individuals of each gender. These groups of individual genotypes were 
reared at the same time in the same incubator and used for the assays. In the 
negative geotaxis assay, we transferred each group of ten flies into an empty 
test vial, gently tapped the flies to the bottom of the vial, and scored the 
number of flies that could climb above the 8-cm mark by 10 seconds after 
the tap (Figure S4B). This test was repeated ten times for each group and 
the mean (average climbing pass rate) was plotted as a single data point 
(Figures 4-6). We basically followed published protocols of assays for negative 
geotaxis (Ali et al. 2011), longevity (Linford et al. 2013), and sensitivity to oxidant 
exposure, (Vrailas-Mortimer et al. 2011). 
 
Databases 
For homology and domain searches, we used Homologene in the NCBI 
BioSystems Database (Geer et al. 2010) and Pfam27.0 (Punta et al. 2012), 
respectively. To search for genomic information of Drosophila melanogaster, we 
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Figure 1 Domains of human ALS2 and its Drosophila homolog (dALS2) and 
an analysis of dALS2 GEF activity.  
(A) hALS2 has an RCC1-like domain (RLD domain) that is composed of five 
RCC1-like repeats (amino acids 93-122, 109-165, 170-216, 527-574, and 
579-625), a Dbl homology domain (DH domain; amino acids 695-882), a 
pleckstrin homology domain (PH domain; amino acids 935-1003), seven 
MORN repeats (amino acids 1049-1071, 1072-1094, 1100-1122, 1123-1143, 
1151-1166, 1198-1220, and 1221-1244), and a VPS9 domain (amino acids 
1552-1654). dALS2 has an RLD domain that is composed of two RCC1-like 
repeats (amino acids 258-361 and 308-361), a PH domain (amino acids 617-
719), six MORN repeats (amino acids 744-765, 766-786, 789-805, 817-835, 
839-855, and 863-885), and a VPS9 domain (amino acids 1373-1481). The 
Pfam program does not predict a DH domain in dALS2. P1425A and L1439A 
indicate substitutions of amino acids in the VPS9 domain of dALS2. (B) 
Analysis of GEF activity of dALS2 in S2 cells (n > 70 cells for each 
transfectioin). Each of the dALS2 forms indicated was co-expressed with a 
FRET probe (Raichu-Rab5[WT]) or its negative control probe (Raichu-
Rab5[S34N]) in S2 cells, and the FRET/CFP ratio was determined. See 
details in the text. Error bars indicate standard deviations. ***: P<0.001 
(ANOVA with Bonferroni) and P=0.852 (student’s t-test). Two other 
experiments gave results similar to this dataset; in every experiment, the 
ratio was increased by 40 % or more when Raichu-Rab5[WT] was co-
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expressed with dALS2[WT].  
 
Figure 2 The dALS2 locus and its protein.  
(A) Exon/intron organization of the dALS2 locus and genomic structures of 
mutant alleles. Gray and orange boxes are UTRs and CDSs, respectively. A 
blue arrow on the wild-type genome indicates the position of the transposon 
insertion, and black arrows indicate primers that were used for genomic PCR. 
Deleted regions in individual alleles are shown with allele numbers. Green 
lines indicate primers that were used in RT-PCR. (B) RT-PCR detection of 
dALS2 mRNA from adults of one of the precise jumpers (Ex101/Ex101) and 
from those of dALS2-/- (Ex44/Ex44). (C) In situ hybridization analysis of 
dALS2 expression in embryos at stage 13 (top) or stage 16 (bottom). Ventral 
views. (Left) Embryo hybridized with a sense probe. (Middle and right) 
Embryo hybridized with an anti-sense probe. The boxed regions in the middle 
panels are magnified in the right. dALS2 is expressed in a wide-range of 
tissues including the epidermis (arrowheads) and the ventral nerve cord 
(boxed regions). Arrows mark unidentified cell types in the ventral nerve cord 
that express dALS2 at a high level. 
 
Figure 3 Phenotypes of NMJs in the dALS2 mutant and those elicited by 
Rab5[S34N] expression in motor neurons.  
(A-D) Phenotypes in wandering third instar larvae. (A and C) NMJs at 
muscles 6/7 (A) and muscle 4 (C) in segment A2 that were stained for HRP 
(green) and Brp (magenta merged with green look white). (B and D) 
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Quantitative analysis. The numbers of synaptic boutons were normalized by 
the surface areas of individual muscles. Bars indicate means. **: P<0.01 ***: 
P<0.001 (ANOVA with Tukey’s HSD posthoc test). Relevant genotypes in A 
and B are Ex101/Ex101 (wild type) and Ex44/Ex44 (dALS2-/-); and those in 
C and D are [OK371-Gal4/UAS-mmRFP] (Control), [OK371-Gal4/+; UAS-
Rab5[S34N]/+] (Rab5S34N), [OK371-Gal4/+; UAS-GFP:Rab5[WT]/+] 
(Rab5WT), [OK371-Gal4/UAS-3HA:dALS2[WT]] (dALS2WT). Scale bars: 20 
µm. 
(E-K) Phenotypes of motor axons in abdomens of 3-4 day-old adult females 
(E, J, K) and 2 w-old adult females (F-I). (E-I) A low-power view of the lateral 
and ventral plates of the wild type (E). The boxed region in E indicates an 
example of motor axon terminals, and blue arrows mark spiracles. (F) High-
power images of axon terminals that innervate ventral abdominal muscles of 
segment A5 of the wild type and the mutant at 2 week-old. Note that neither 
of the images in F is a magnification of the boxed region in E. The area of 
each presynaptic arbor was defined as a polygon outlined with a magenta 
broken line, which was quantitatively analyzed in G-I. Quantifications of the 
area size (G), the number of boutons in each area (H), and the number of 
normalized boutons (I). **: P<0.01 (student’s t-test). (J and K) Low-power 
ventral views along the midlines (magenta broken lines). The boxed regions 
highlight distinct growth of axon terminals between the two genotypes. Scale 
bars: 50 µm (E, J, K) and 20 µm (F). Relevant genotypes in E-I are [OK371-
Gal4 UAS-mCD8:3xEGFP/OK371-Gal4 UAS-mCD8:3xEGFP] (E), [OK371-
Gal4 UAS-mCD8:3xEGFP/OK371-Gal4 UAS-mCD8:3xEGFP; Ex101/Ex101] 
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(wild type in F-I), [OK371-Gal4 UAS-mCD8:3xEGFP/OK371-Gal4 UAS-
mCD8:3xEGFP; Ex44/Ex44] (dALS2-/- in F-I); and those in J and K are 
[OK371-Gal4 UAS-mCD8:3xEGFP/UAS-mmRFP] (J), and [OK371-Gal4 
UAS-mCD8:3xEGFP/+; UAS-Rab5[S34N]/+] (K).  
 
Figure 4 The dALS2 mutant exhibited age-dependent locomotor dysfunction.  
Wild type and dALS2-/- were assayed for negative geotaxis at the indicated 
ages, scoring each gender separately. The genotypes of the wild type in A 
and B are Ex101/Ex101 and Ex95/Ex95, respectively, while the genotype of 
the mutants is Ex44/Ex44. *** P<0.001 (student’s t-test).  
 
Figure 5 The locomotion deficit of the mutant was rescued by widely 
expressing the dALS2 transgene   
Rescue experiment of the locomotion deficit of the dALS2-/- mutant by using 
Ubi-Gal4. Females and males of the four genotypes were assayed for 
negative geotaxis at 1 week (A) or 2 weeks (B) after eclosion. Relevant 
detailed genotypes (from left to right in each graph) were [Ubi-Gal4/UAS-
mmRFP; Ex101/Ex101] (Ubi>RFP; WT), [Ubi-Gal4/UAS-dALS2; 
Ex101/Ex101] (Ubi>dALS2; WT), [Ubi-Gal4/UAS-mmRFP; Ex44/Ex44] 
(Ubi>RFP; dALS2-/-), and [Ubi-Gal4/UAS-dALS2; Ex44/Ex44] (Ubi>dALS2; 
dALS2-/-). Magenta asterisks indicate statistically significant differences of the 
cohort from the wild type (Ubi>RFP; WT); and blue asterisks from the mutant 
(Ubi>RFP; dALS2-/-). *: P<0.05; **: P<0.01; NS: Statistically not significant (P 
> 0.05). ANOVA with Tukey’s HSD posthoc test. In the top right graph, the 
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significance of the difference between Ubi>RFP; dALS2-/- and Ubi>dALS2; 
dALS2-/- is marginal, so the exact P value is provided. 
 
Figure 6 Locomotion deficit rescue experiment using a motor neuron-
specific Gal4 driver.  
Females and males of the four genotypes were assayed for negative 
geotaxis at 1 week (A) or 2 weeks (B) after eclosion. Relevant detailed 
genotypes (from left to right in each graph) were [OK371-Gal4/UAS-
mmRFP; Ex101/Ex101] (OK371>RFP; WT), [OK371-Gal4/UAS-dALS2; 
Ex101/Ex101] (OK371>dALS2; WT), [OK371-Gal4/UAS-mmRFP; 
Ex44/Ex44] (OK371>RFP; dALS2-/-), and [OK371-Gal4/UAS-dALS2; 
Ex44/Ex44] (OK371>dALS2; dALS2-/-). Magenta asterisks indicate statistically 
significant differences of the cohort from the wild type (OK371>RFP; WT); and 
blue asterisks from the mutant (OK371>RFP; dALS2-/-). *: P<0.05; **: P<0.01; 
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Figure S1 Human and Drosophila Rab5-GEFs and GAPs.  
Human Gapex-5 and its Drosophila homolog, CG1657, have RasGAP (blue 
boxes) and VPS9 (red boxes) domains. Rabex-5 and dRabex-5 have A20-
like zinc finger (pink boxes) and VPS9 domains. Rin1 and its Drosophila 
homolog Sprint have Src homology 2 (SH2; aqua blue boxes), VPS9, and 
RA (brown boxes) domains. RN-tre and RabGap-5 have Tre-2, Bub2, and 
Cdc16 (TBC; purple boxes) domains. RabGap-5 and its Drosophila 
homolog, CG11241, have Src homology 3 (SH3; green boxes) and RUN 
domains. 
 
Figure S2 Multiple sequence alignment of VPS9 domains of Rab5 GEFs.  
Amino-acid sequences of Human ALS2 and Drosophila CG7158 are 
marked with asterisks. Residues that are conserved among all of the eight 
GEFs are highlighted by white letters in black boxes, while resides 
conserved among five to seven GEFs are by white letters in gray boxes. 
Those conserved among only three or four GEFs are shown by black letters 
in gray boxes. The red boxes represent the residues that are mutated in 
this study (Figure 1). 
 
Figure S3 Phenotypes of class IV da neurons in the dALS2 mutant. 
(A and B) Class IV da neurons (ddaC) in wandering 3rd instar larvae of the 
wild type (A) or the dALS2 mutant (B). The area of the dendritic arbor (light 
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blue-colored region) and that of the dorsal body surface (box outlined in 
red) are superimposed on original images. The total length (TL) and 
coverage index (CI) are documented. Genotypes are [Gr28b.c-Gal4 UAS-
mCD8:GFP/+; Ex101/Ex101] (A) and [Gr28b.c-Gal4 UAS-mCD8:GFP/+; 
Ex44/Ex44] (B). (C) Quantifications of total branch lengths of the neurons 
(left), the numbers of branch endings (middle), and the coverage index 
(right). *: P<0.05; **: P<0.01 (student’s t-test). Scale bars: 100 µm. 
 
Figure S4 Negative geotaxis assay.  
(A) Snap shots that were taken 5 seconds after the tap. (Left) Climbing 
control flies (OK371-Gal4 UAS-mCD8:3×EGFP/UAS-mmRFP). (Right) 
Rab5[S34N]-expressing flies (OK371-Gal4 UAS-mCD8:3×EGFP/+; UAS-
Rab5[S34N]/+) hardly climbed. (B) A schematic representation of the 
negative geotaxis assay. The score of the climbing pass rate is 70% in this 
example. (C and D) 4 week-old wild-type (Ex101/Ex101) and dALS2-/- 
(Ex44/Ex44) flies, respectively. The pictures were taken at 0, 5, and 8 
seconds after the tap. Individual tracks of the flies, traced from the video 
movie, are shown by different colors. 
 
Figure S5 Aging was not accelerated in the dALS2 mutant.  
(A) Confocal images of whole-mount brains of 3-4 day old or 2-week-old 
flies, which were stained for polyubiquitin. (B) Total lysates of 1-week or 3-
week old adult heads were probed with anti-polyubiquitin, anti-actin, or anti-
p62 antibodies. An arrow identifies p62, which co-migrated with the 100 
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kDa marker protein. Genotypes are Ex101/Ex101 (wild type) and 
Ex44/Ex44 (dALS2-/-).  
 
Figure S6 Life span assay 
Adult survivorship of the wild type (magenta) and dALS2-/- (blue). Males and 
females were reared separately after one-day mating. (A, C, and E) males and 
(B, D, and F) females. The genotypes of the wild type are Ex101/Ex101 (A and 
B) and Ex95/Ex95 (C-F). The genotypes of dALS2-/- mutants are Ex44/Ex44 (A-
D) and Ex54/Ex54 (E and F). Survivorship data were analyzed using the log-rank 
test and p values are indicated in individual panels. 
 
Supplemental movie 1 
Climbing ability of the control adults (0-3 days old). The genotype is OK371-
Gal4/UAS-mmRFP. 
 
Supplemental movie 2 
Climbing ability of Rab5[S34N]-expressing adults (0-3 days old). After the tap, the 
flies were recorded longer than 10 seconds. The genotype is OK371-Gal4/+; 
UAS-Rab5[S34N]/+. 
 
 
 
